InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,101.24
(
-0.29%
)
US TECH 100
21,156.80
(
-0.70%
)
Dow Jones
44,424.25
(
-0.32%
)
Brent Oil
77.63
(
0.00%
)
Bitcoin
105,061.30
(
0.32%
)
Post# of 481631
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Doktornolittle

Send PM Follow Ignore
Followers 34
Posts 2680
Boards Moderated 0
Alias Born 10/28/2013

Doktornolittle

Re: mixedup post# 12428

Friday, 08/07/2015 7:14:19 PM

Friday, August 07, 2015 7:14:19 PM

Post# of 481631
Good thing about that article being old is that the Phase 2 trial for Anavex 2-73 was likely designed with every detail of those FDA policy changes taken into account.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing • BLO • Jan 24, 2025 8:49 AM

UC Asset Announces Plan of Secondary Public Offering via Reg A • UCASU • Jan 23, 2025 9:30 AM

Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM

North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM

HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM

Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM

Start posting your company's news
Only $200 per official company press release!